Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling

Figure 2

(a) 5-HT level, (b) sucrose preference, (c–d) locomotion scores, and exploratory scores in control and CUMS groups. Data are (). .

(a)

(b)

(c)

(d)